Global PCR for POC Diagnostics Market 2022

REPORT CODE: HB24330G INDUSTRY: COMPANIES MENTIONED: , , , ,

Description

Sometimes called molecular photocopying, the polymerase chain reaction (PCR) is a fast and inexpensive technique used to amplify – copy – small segments of DNA. PCR is valuable in a number of laboratory and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses, and diagnosis of genetic disorders. According to StrategyHelix, the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is expected to increase by US$ 2,037.6 million during 2022-2028, expanding at a CAGR of 8.5% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics. The global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is segmented on the basis of product, and region. Based on product, the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is categorized into equipment, kits. Kits was the largest revenue contributor to the global pcr for poc diagnostics market in 2021 and is anticipated to show the highest growth rate during the forecast period. Geographically, the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest share of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market in 2021 and is anticipated to hold its share during the forecast period.

The equipment market is further segmented into multi-kit, and single kit. According to the research, the single kit segment had the largest share in the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market. Furthermore, the kit market has been categorized into infectious disease, multi-analyte panels, sexually transmitted diseases (STDs), single analyte, and others. StrategyHelix research indicates that the single analyte segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years.

Key companies profiled in the report include Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid, Qiagen N.V., Roche Holding AG.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Product: equipment, kits
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028


Key Benefits for Stakeholders

– Get a comprehensive picture of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market overview
Part 3. Market breakdown by product
– Equipment
– Kits
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– Abbott Laboratories
– Bio-Rad Laboratories, Inc.
– Cepheid
– Qiagen N.V.
– Roche Holding AG
About StrategyHelix
Disclaimer


USD 650

Product Type

Industry Briefing

Release Date

April 2022

Region

Global

Pages

19

REQUEST SAMPLE

Global PCR for POC Diagnostics Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global PCR for POC Diagnostics Market 2022

Please fill out our form and we will get back to you.

login